Literature DB >> 8112850

Immunological and molecular characterization of Helicobacter felis urease.

T D Gootz1, G I Perez-Perez, J Clancy, B A Martin, A Tait-Kamradt, M J Blaser.   

Abstract

Urease activity has recently been shown to be an important virulence determinant for Helicobacter pylori, allowing it to survive the low pH of the stomach during colonization. Experimental murine infection with Helicobacter felis is now being used as a model for H. pylori infection to study the effects of vaccines, antibiotics, and urease inhibitors on colonization. However, little information comparing the ureases of H. felis and H. pylori is available. Urease was partially purified from the cell surface of H. felis ATCC 49179 by A-5M agarose chromatography, resulting in an eightfold increase in specific activity over that of crude urease. The apparent Km for urea for the partially purified urease was 0.4 mM, and the enzyme was inhibited in a competitive manner by flurofamide (50% inhibitory concentration = 0.12 microM). Antiserum to whole cells of H. pylori recognized both H. pylori and H. felis urease B subunits. Antiserum raised against H. felis whole cells recognized the large and small autologous urease subunits and the cpn60 heat shock molecule in both H. felis and H. pylori. However, this antiserum showed only a weak reaction with the B subunit of H. pylori urease. Two oligomeric DNA sequences were used as probes to evaluate the relatedness of H. felis and H. pylori urease gene sequences. One 30-mer from the ureA sequence, which had been shown previously to be specific for H. pylori, failed to hybridize to H. felis genomic DNA. A probe to the putative coding sequence for the active site of the H. pylori ureB subunit hybridized at low intensity to a 2.8-kb fragment of BamHI-HindIII-digested H. felis DNA, suggesting that the sequences were homologous but not identical, a result confirmed from the recently published sequences of ureA and ureB from H. felis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112850      PMCID: PMC186185          DOI: 10.1128/iai.62.3.793-798.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

2.  Evaluation of three Campylobacter pylori antigen preparations for screening sera from patients undergoing endoscopy.

Authors:  F J Bolton; D N Hutchinson
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

Review 3.  Campylobacter pylori and gastroduodenal disease.

Authors:  G E Buck
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

4.  Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis.

Authors:  J I Wyatt; B J Rathbone; M F Dixon; R V Heatley
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

5.  Two-dimensional gel electrophoresis and immunoblotting of Campylobacter pylori proteins.

Authors:  B E Dunn; G I Perez-Perez; M J Blaser
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

6.  Isolation of a spiral-shaped bacterium from the cat stomach.

Authors:  A Lee; S L Hazell; J O'Rourke; S Kouprach
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

7.  Campylobacter pylori antibodies in humans.

Authors:  G I Perez-Perez; B M Dworkin; J E Chodos; M J Blaser
Journal:  Ann Intern Med       Date:  1988-07-01       Impact factor: 25.391

8.  Antigenic conservation of the ureases of spiral- and helical-shaped bacteria colonising the stomachs of man and animals.

Authors:  D G Newell; A Lee; P R Hawtin; M J Hudson; A R Stacey; J Fox
Journal:  FEMS Microbiol Lett       Date:  1989-11       Impact factor: 2.742

9.  Molecular cloning and expression of Campylobacter pylori species-specific antigens in Escherichia coli K-12.

Authors:  C L Clayton; B W Wren; P Mullany; A Topping; S Tabaqchali
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

10.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.

Authors:  R D Leunk; P T Johnson; B C David; W G Kraft; D R Morgan
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

View more
  5 in total

1.  Urease from a potentially pathogenic coccoid isolate: purification, characterization, and comparison to other microbial ureases.

Authors:  S G Lee; D H Calhoun
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.

Authors:  J V Solnick; D B Schauer
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

3.  Development of a PCR-restriction fragment length polymorphism assay using the nucleotide sequence of the Helicobacter hepaticus urease structural genes ureAB.

Authors:  Z Shen; D B Schauer; H L Mobley; J G Fox
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection.

Authors:  R L Ferrero; J M Thiberge; M Huerre; A Labigne
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

5.  Serologic host response to Helicobacter pylori and Campylobacter jejuni in socially housed Rhesus macaques (Macaca mulatta).

Authors:  Sabine Kienesberger; Guillermo I Perez-Perez; Juan L Rivera-Correa; Rafael Tosado-Acevedo; Huilin Li; Andre Dubois; Janis A Gonzalez-Martinez; Maria Gloria Dominguez-Bello; Martin J Blaser
Journal:  Gut Pathog       Date:  2012-08-24       Impact factor: 4.181

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.